Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
about
Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsTL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRISphingolipid modulation of angiogenic factor expression in neuroblastoma.Lack of correlation between MYCN expression and the Warburg effect in neuroblastoma cell lines.Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells.Angiostatic treatment of neuroblastoma.Anti-angiogenic SPARC peptides inhibit progression of neuroblastoma tumors.Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.In vitro and in vivo imaging of prostate cancer angiogenesis using anti-vascular endothelial growth factor receptor 2 antibody-conjugated quantum dot.Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.Thalidomide and lenalidomide: Mechanism-based potential drug combinations.Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell linesRadiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECTNeuroblastoma in dialog with its stroma: NTRK1 is a regulator of cellular cross-talk with Schwann cells.Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaPharmacologic management of high-risk neuroblastoma in childrenCross-talk between Schwann cells and neuroblasts influences the biology of neuroblastoma xenograftsIntrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastomaSunitinib suppress neuroblastoma growth through degradation of MYCN and inhibition of angiogenesisOct-4+/Tenascin C+ neuroblastoma cells serve as progenitors of tumor-derived endothelial cells.Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors.An unexpected role for caspase-2 in neuroblastoma.Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastomaPresence of cancer-associated fibroblasts inversely correlates with Schwannian stroma in neuroblastoma tumorsMonitoring Breast Tumor Lung Metastasis by U-SPECT-II/CT with an Integrin α(v)β(3)-Targeted Radiotracer( 99m)Tc-3P-RGD(2).Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.Delivery of antiangiogenic agents for cancer gene therapy.Notch signaling regulates tumor-induced angiogenesis in SPARC-overexpressed neuroblastomaColigand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramerAngiogenesis in a human neuroblastoma xenograft model: mechanisms and inhibition by tumour-derived interferon-gamma.N-myc is a novel regulator of PI3K-mediated VEGF expression in neuroblastoma.Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkersImproving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartmentsImproving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkersVascular patterns provide therapeutic targets in aggressive neuroblastic tumorsNeuroblastoma and MYCNBombesin induces angiogenesis and neuroblastoma growth.
P2860
Q24292464-33467B4B-ACC2-4F71-98EE-93D21E972DE1Q28540575-C74A4C88-D744-4A0E-86F5-E56F4DA9A8B9Q30425699-EF3DCF51-457D-43D7-B05C-4D5B2D2701B9Q33369231-B78028A5-D668-4635-A6A8-2C5B8CE1D39CQ33655421-EF86BC22-AE03-42D3-88F5-945A8B960E74Q33664081-42B4BA70-3A3A-422C-8FE5-0908F38D75F9Q33955200-351B5BF4-1314-41E3-A2B1-B5E557052E84Q34200348-0CDCCC22-8D30-4EE2-AB11-83E40C9A2F9CQ34512169-D0E2F864-EB41-4DC3-9B35-FAE60DBCDC24Q34549381-26EF06F8-B13E-4EF1-8177-6CDAE724A9BEQ34706749-A7E007DE-2532-4491-BDF6-B230271A04BBQ34775475-CD9F3504-FBFF-4867-ACA2-1E5937B4E203Q34780646-507E9B6E-3036-438F-914F-C9492D298DE5Q34912643-1EDF61F7-1356-4225-96B6-6DB03E2EFCB9Q34956841-41BD2F42-35BF-490F-AD00-30D968841467Q34983575-AA9C6B05-2C90-43AB-A3C1-71C20D0B86AAQ35064095-A877C778-C86A-47FB-BF84-80034F690084Q35083674-ED2F2633-18C1-4850-8A3B-134A1DD89B73Q35131527-2FC1392E-44F0-4CFD-B3AD-F8F002CC8217Q35156047-4877C738-8327-4246-B8A2-A29D6DDC5485Q35348365-D1E30B8B-F948-4C19-93EE-BC8F1D40F470Q35599819-93850D88-5EC0-4F08-BD89-ECC618B0D98DQ35679550-499ED888-1618-4925-8866-63C10910CD34Q35839982-E7C177D2-1C2F-4736-864F-A315C5262A8DQ35945448-41B808E2-570A-4268-8DF0-9BF60F8EF51AQ36052978-0E096382-249C-4B30-9944-19054B49C691Q36108956-87CF9405-1A9C-4100-88AF-53BFF809A5BCQ36200143-0FC357B7-FACB-41D2-9E91-12708DA24581Q36481114-E1611595-45F6-422B-9C96-A9B920BA08C3Q36515561-3C73B8BA-091B-4660-975A-DB87A70CB3B6Q36614375-226A9123-A407-4335-9598-0F10E4A75500Q37038002-3133A6E9-A327-45E9-ACB9-2F4A21010A79Q37060623-989962B3-C609-4ECF-9041-FB21E8245681Q37081396-4E6C0C08-DFBF-4007-98E4-BCDA0E24A71CQ37086200-47C51FDE-9495-4929-9A37-6C422131F4ADQ37154811-3E9D18DD-8646-4B83-AB32-F82FE0144F36Q37178786-5CE30D21-F702-4F08-920A-F57B7F19EBF6Q37190218-7606023F-5F06-4316-A31C-28CFC3FD6406Q37201479-A1218DBE-7F94-4E74-87FC-75936742C715Q37259715-46AC9868-FBF1-4205-B30D-FB1833C7CFCA
P2860
Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma.
description
1996 nî lūn-bûn
@nan
1996 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@ast
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@en
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@nl
type
label
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@ast
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@en
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@nl
prefLabel
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@ast
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@en
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@nl
P2093
P1476
Tumor angiogenesis correlates ...... utcome in human neuroblastoma.
@en
P2093
A W Rademaker
S E Crawford
P304
P356
10.1200/JCO.1996.14.2.405
P407
P577
1996-02-01T00:00:00Z